704 related articles for article (PubMed ID: 17059896)
1. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
[TBL] [Abstract][Full Text] [Related]
4. Exploring potential noninvasive biomarkers in eosinophilic esophagitis in children.
Subbarao G; Rosenman MB; Ohnuki L; Georgelas A; Davis M; Fitzgerald JF; Molleston JP; Croffie JM; Pfefferkorn MD; Corkins MR; Lim JR; Steiner SJ; Schaefer E; Gleich GJ; Gupta SK
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):651-8. PubMed ID: 21694637
[TBL] [Abstract][Full Text] [Related]
5. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
[TBL] [Abstract][Full Text] [Related]
6. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
[TBL] [Abstract][Full Text] [Related]
7. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive biomarkers identify eosinophilic esophagitis: A prospective longitudinal study in children.
Wechsler JB; Ackerman SJ; Chehade M; Amsden K; Riffle ME; Wang MY; Du J; Kleinjan ML; Alumkal P; Gray E; Kim KA; Wershil BK; Kagalwalla AF
Allergy; 2021 Dec; 76(12):3755-3765. PubMed ID: 33905577
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
Kim CK; Callaway Z; Fletcher R; Koh YY
J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
[TBL] [Abstract][Full Text] [Related]
11. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
12. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis.
Fujiwara H; Morita A; Kobayashi H; Hamano K; Fujiwara Y; Hirai K; Yano M; Naka T; Saeki Y
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):429-32. PubMed ID: 12392390
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
14. Normalized serum eosinophil peroxidase levels are inversely correlated with esophageal eosinophilia in eosinophilic esophagitis.
Wright BL; Ochkur SI; Olson NS; Shim KP; Jacobsen EA; Rank MA; Dellon ES; Lee JJ
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29228243
[TBL] [Abstract][Full Text] [Related]
15. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic criteria for eosinophilic esophagitis: a 5-year retrospective review in a pediatric population.
Lai AL; Girgis S; Liang Y; Carr S; Huynh HQ
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):63-70. PubMed ID: 19465874
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
[TBL] [Abstract][Full Text] [Related]
18. Addressing diagnostic dilemmas in eosinophilic esophagitis using esophageal epithelial eosinophil-derived neurotoxin.
Thomas J; Hopson P; Deb C; Bornstein J; Mehta D; Bittar K; Smadi Y
J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):304-312. PubMed ID: 38374551
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
[TBL] [Abstract][Full Text] [Related]
20. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.
Sayej WN; Patel R; Baker RD; Tron E; Baker SS
J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):393-9. PubMed ID: 19633574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
